ketamine has been researched along with Dyskinesia, Drug-Induced in 14 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dextromethorphan was more effective than ketamine in potentiating morphine-induced antinociception." | 1.30 | Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats. ( Hedman, U; Plesan, A; Wiesenfeld-Hallin, Z; Xu, XJ, 1998) |
| "The purpose of this article is to document that ketamine hydrochloride, administered at an anesthetic dosage of about 100 mg/kg, produces tongue contractile activity in the rat." | 1.27 | Ketamine as a pharmacological model for tongue dyskinesia. ( Aldes, LD; Chronister, RB; Marco, LA; Prater, SR, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Pottenger, AE | 1 |
| Bartlett, MJ | 4 |
| Sherman, SJ | 4 |
| Falk, T | 4 |
| Morrison, HW | 1 |
| Flores, AJ | 1 |
| Ye, T | 2 |
| Smidt, SI | 1 |
| Dollish, HK | 1 |
| Stancati, JA | 1 |
| Farrell, DC | 1 |
| Parent, KL | 2 |
| Doyle, KP | 1 |
| Besselsen, DG | 1 |
| Heien, ML | 2 |
| Cowen, SL | 2 |
| Steece-Collier, K | 1 |
| Joseph, RM | 1 |
| LePoidevin, LM | 1 |
| Laude, ND | 1 |
| Lazarus, LB | 1 |
| Estevez, M | 1 |
| Bimpisidis, Z | 1 |
| Öberg, CM | 1 |
| Maslava, N | 1 |
| Cenci, MA | 1 |
| Lundblad, C | 1 |
| Hans, ML | 1 |
| Maxwell, C | 1 |
| Ehrlichman, RS | 1 |
| Metzger, K | 1 |
| Liang, Y | 1 |
| Siegel, SJ | 1 |
| Lowman, AM | 1 |
| Khanna, JM | 1 |
| Morato, GS | 1 |
| Chau, A | 1 |
| Shah, G | 1 |
| Plesan, A | 1 |
| Hedman, U | 1 |
| Xu, XJ | 1 |
| Wiesenfeld-Hallin, Z | 1 |
| Marco, LA | 6 |
| Joshi, RS | 3 |
| Cepeda, NJ | 1 |
| Rhyne, DB | 1 |
| Reed, TF | 3 |
| Aldes, LD | 4 |
| Chronister, RB | 4 |
| Pendleton, R | 1 |
| Brigham, TE | 1 |
| Prater, SR | 1 |
14 other studies available for ketamine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Corpus Striatum; Disease Models, A | 2021 |
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.
Topics: Anesthetics, Dissociative; Animals; Antiparkinson Agents; Brain-Derived Neurotrophic Factor; Dendrit | 2020 |
Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
Topics: Analgesics; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 2021 |
Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model.
Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ketamine; | 2016 |
Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease.
Topics: Anesthetics; Animals; Basal Ganglia; Cerebrovascular Circulation; Dyskinesia, Drug-Induced; Dyskines | 2017 |
Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures.
Topics: Animals; Anti-Dyskinesia Agents; Delayed-Action Preparations; Drug Delivery Systems; Dyskinesia, Dru | 2007 |
D-cycloserine enhances rapid tolerance to ethanol motor incoordination.
Topics: Animals; Central Nervous System Depressants; Cycloserine; Dose-Response Relationship, Drug; Drug Tol | 1995 |
Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Anesthetics, Dissociative; Animals; Antitussive Agents; C | 1998 |
A ketamine-induced rat model of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Clozapine; Dizocilpine Maleate; Dyskinesia, Drug-Induced; Haloperidol | 1992 |
Unitary correlates of linguo-pharyngeal events in a dyskinetic rat model.
Topics: Animals; Deglutition; Dyskinesia, Drug-Induced; Electric Stimulation; Hypoglossal Nerve; Ketamine; L | 1991 |
Metoclopramide fails to suppress linguopharyngeal events in a rat dyskinesia model.
Topics: Animals; Deglutition; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Ind | 1989 |
Ketamine-induced tongue protrusions in rats.
Topics: Animals; Deglutition; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Hypoglo | 1989 |
Ketamine as a pharmacological model for tongue dyskinesia.
Topics: Animals; Dyskinesia, Drug-Induced; Female; Ketamine; Rats; Rats, Inbred Strains; Tongue | 1988 |
An electrographic characterization of ketamine-induced linguopharyngeal motor activity.
Topics: Animals; Deglutition; Dyskinesia, Drug-Induced; Electromyography; Female; Haloperidol; Ketamine; Rat | 1988 |